Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.
W
W

Waters

Balita

Reuters - 21 oras ang nakaraan

U.S. STOCKS Avery Dennison, Snap-On, Avadel Pharma

BUZZ-U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street gained on Thursday, with the S&P 500 and the Dow touching intraday record highs, driven by TSMC's upbeat forecast and a bigger-than-expected rise in monthly retail sales indicating a strong U.S.
A
B
C
E
I
N
N
R
S
S
S
U
U
U
U
T
U
W
W
A
E
M
S
Reuters - 1 araw ang nakaraan

U.S. STOCKS PPG Industries, Travelers, ShiftPixy

BUZZ-U.S. STOCKS ON THE MOVE-PPG Industries, Travelers, ShiftPixy Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes were set to rise on Thursday, with an upbeat forecast from TSMC boosting semiconductor stocks, while a bigger-than-expected rise in September retail sales pointed to a strong U.S.
A
A
B
C
C
E
I
N
R
S
U
U
S
T
U
W
W
P
R
Reuters - 1 araw ang nakaraan

US life sciences firms get lift from Sartorius' results

BUZZ-US life sciences firms get lift from Sartorius' results ** Shares of US life sciences firms rise after German peer Sartorius's SATG.DE better-than-expected bioprocessing order intake in its nine-month results ** Premarket, Danaher DHR.N up 3.4%, Thermo Fisher Scientific TMO.N up 2.1% and Waters WAT.N up 1.7% ** Sartorius' order intake rose 6.6
T
W
Reuters - 2 araw ang nakaraan

U.S. STOCKS Wave Life Sciences, Dominion Energy, Voyager Therapeutics

BUZZ-U.S. STOCKS ON THE MOVE-Wave Life Sciences, Dominion Energy, Voyager Therapeutics Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq were little changed on Wednesday, with declines in heavily weighted technology megacaps limiting gains as investors turned to small-cap and financial stocks after a slew of upbeat bank earnings.
A
A
I
J
S
U
U
G
T
W
A
Reuters - 2 araw ang nakaraan

U.S. STOCKS Wave Life Sciences, Dominion Energy, Voyager Therapeutics

BUZZ-U.S. STOCKS ON THE MOVE-Wave Life Sciences, Dominion Energy, Voyager Therapeutics The Dow regained some lost ground on Wednesday although the S&P 500 and the Nasdaq stumbled, dragged lower by declines in megacap technology stocks, while the broader market gained from upbeat quarterly earnings from banks, notably Morgan Stanley. .N At 11:32 ET, the Dow Jones Industrial Average .DJI was up 0.4% to 42,924.64 at 11:34, pares gain.
A
A
C
D
I
S
J
U
U
U
G
T
W
A
Reuters - 2 araw ang nakaraan

U.S. STOCKS United Airlines, Morgan Stanley, Autodesk

BUZZ-U.S. STOCKS ON THE MOVE-United Airlines, Morgan Stanley, Autodesk Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were on track for a muted open on Wednesday, following a selloff in tech and oil stocks in the previous session, as investors parsed quarterly results from banks including Morgan Stanley.
A
A
C
I
A
J
U
U
U
I
W
A
Reuters - 2 araw ang nakaraan

U.S. STOCKS Gold miners, J.B. Hunt, Cisco Systems

BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, J.B. Hunt, Cisco Systems Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures were largely subdued on Wednesday, following a selloff in tech and oil stocks in the previous session, as investors awaited quarterly results from Morgan Stanley and other banks.
C
I
A
J
U
W
Reuters - 2 araw ang nakaraan

Bernstein expects a 'not so scary' Q3 for US life sciences firms

BUZZ-Bernstein expects a 'not so scary' Q3 for US life sciences firms ** Brokerage Bernstein expects a "not so scary" Q3 earnings season for U.S. life sciences and tools firms, which "would be a real treat" for investors ** "With the recovery timeline for life science tools continuing to push out (further), some investors feel like they have been t
A
I
T
W
Reuters - 1 linggo ang nakaraan

U.S. Humana, Portillos, Waters Corp

U.S. RESEARCH ROUNDUP-Humana, Portillos, Waters Corp Oct 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Humana, Portillos and Waters on Tuesday. HIGHLIGHTS * Frontier Communications Parent Inc FYBR.O : TD Cowen cuts to hold from buy * Humana HUM.N : RBC cuts target price to $265 from $400 * Portillos Inc PTLO.O : Stephens cuts to equal-weight from overweight * Waters Corp WAT.N : Jefferies raises to buy from hold
B
C
C
C
H
C
F
G
S
W
C
C
P
Reuters - 1 buwan ang nakaraan

U.S. STOCKS Gold miners, silver miners, Warner Bros Discovery

BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Warner Bros Discovery Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street was little changed on Thursday after hot producer prices data kept a smaller, 25-basis-point interest-rate cut by the Federal Reserve firmly on the table, while vaccine maker Moderna's shares slumped following a downbeat revenue forecast.
G
K
M
U
U
D
W
A
Reuters - 2 buwan ang nakaraan

Waters Corp Appoints Heather Knight To Board Of Directors

BRIEF-Waters Corp Appoints Heather Knight To Board Of Directors Aug 14 (Reuters) - Waters Corp WAT.N : WATERS CORPORATION APPOINTS HEATHER KNIGHT TO BOARD OF DIRECTORS Source text for Eikon: ID:nPnc7ZkDqa Further company coverage: WAT.N
W
Reuters - 3 buwan ang nakaraan

Mettler-Toledo forecast dull third-quarter profit on weak China demand

Mettler-Toledo forecast dull third-quarter profit on weak China demand Aug 1 (Reuters) - Medical equipment maker Mettler-Toledo International MTD.N forecast third-quarter profit below estimates on Thursday, a sign of a weaker-than-expected recovery in sales in its key market China. Lifesciences firms including lab equipment maker Mettler-Toledo have seen sluggish demand for their instruments used in drug development as cash-strapped biotech clients try to navigate a funding crunch amid high inte
W
M
Reuters - 3 buwan ang nakaraan

Bio-Rad Labs cuts annual revenue forecast on weak demand for diagnostics products

Bio-Rad Labs cuts annual revenue forecast on weak demand for diagnostics products Aug 1 (Reuters) - Bio-Rad Laboratories BIO.N cut its annual revenue growth forecast on Thursday, dragged down by weak demand for clinical diagnostics products from biotech clients. Shares of the diagnostics company fell 20% after the bell. Bio-Rad expects its full-year 2024 adjusted revenue to decline by about 2.5% to 4% on a currency-neutral basis, compared to its previous estimate of 1.0% to 2.5%.
T
W
Reuters - 3 buwan ang nakaraan

U.S. CH Robinson Worldwide, Dayforce, Entegris

U.S. RESEARCH ROUNDUP-CH Robinson Worldwide, Dayforce, Entegris Aug 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CH Robinson Worldwide, Dayforce and Entegris, on Thursday. HIGHLIGHTS * CH Robinson Worldwide Inc CHRW.O : JP Morgan raises to overweight from neutral * Dayforce Inc DAY.N : Piper Sandler raises to overweight from neutral * Entegris Inc ENTG.O : Seaport Research Partners raises to buy from neutral * M
B
C
D
E
M
Q
S
V
A
C
D
E
L
T
P
W
A
B
C
Reuters - 3 buwan ang nakaraan

U.S. STOCKS Kraft Heinz, Marriott, Mastercard

BUZZ-U.S. STOCKS ON THE MOVE-Kraft Heinz, Marriott, Mastercard Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq and the S&P 500 jumped around 2% on Wednesday, as investors hoped for hints from the Federal Reserve on the timing of rate cuts, a bullish forecast from AMD boosted chip stocks and Microsoft slipped after a higher spending forecast.
B
B
D
G
I
M
M
M
N
S
V
A
K
T
U
U
G
U
W
A
B
Reuters - 3 buwan ang nakaraan

Waters Corp climbs after Q2 results beat

BUZZ-Waters Corp climbs after Q2 results beat Updates ** Shares of lab equipment maker Waters Corp WAT.N rise ~4.1% to $341.09, their highest since May ** WAT reports Q2 adj. profit of $2.63/shr vs analysts' average estimate of $2.56/shr - LSEG data ** Posts quarterly revenue of $708.5 mln vs analysts' expectation of $700.1 mln ** Company forecasts annual adj.
A
W
Reuters - 3 buwan ang nakaraan

Waters Corp falls on annual profit forecast cut

BUZZ-Waters Corp falls on annual profit forecast cut ** Shares of lab equipment maker Waters Corp WAT.N fall ~2.3% to $320.01 premarket ** Co forecasts annual adj. profit between $11.55 and $11.65 per share below previous forecast of $11.75-$12.05 ** Evercore analyst Vijay Kumar says WAT's forecast cut was "generally expected" given peer Agilent's A.N revenue forecast cut in May ** WAT reports Q2 adj.
A
W
Reuters - 3 buwan ang nakaraan

Waters Corp cuts annual profit forecast on weak demand for lab equipment

Waters Corp cuts annual profit forecast on weak demand for lab equipment July 31 (Reuters) - Waters Corp WAT.N lowered its annual profit forecast as it anticipates reduced demand for its products and services used in drug development and research. Milford, Massachusetts-based Waters supplies lab equipment and technology for scientists across the world, with the majority of its revenue coming in from biopharma clients who use its tools for research and drug development.
T
W
Reuters - 3 buwan ang nakaraan

Waters Q2 Adjusted EPS USD 2.63 Vs. IBES Estimate USD 2.56

BRIEF-Waters Q2 Adjusted EPS USD 2.63 Vs. IBES Estimate USD 2.56 Jul 31 (Reuters) - Waters Q2 EPS USD 2.4. Q2 sales USD 709 million vs. IBES estimate USD 700.1 million outlook FY adjusted EPS USD 11.55-11.65 outlook FY sales growth -2 to -0.5%
W
Reuters - 3 buwan ang nakaraan

Waters Corp <WAT.N> expected to post earnings of $2.56 a share - Earnings Preview

Waters Corp expected to post earnings of $2.56 a share - Earnings Preview Waters Corp WAT.N , WAT is expected to show a fall in quarterly revenue when it reports results on July 31 for the period ending June 30 2024 The Milford Massachusetts-based company is expected to report a 5.5% decrease in revenue to $700.079 million from $740.58 million a year ago, according to the mean estimate from 16 analysts, based on LSEG data.The company's guidance on May 7 2024, for the period ended June 30, was fo
W

Kundisyon

Mga Patok na Assets

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.